Radiation safety management for stereotactic body radiation therapy incidentally concurrent with Pluvicto® (Lu-177) therapy - a case report
{{output}}
A patient with castration-resistant prostate cancer (CRPC) was referred to our clinic seeking palliative management of a painful metastasis in the left pelvis. At the time of referral, the patient was receiving [177Lu]Lu-PSMA 617 (Pluvicto®) therapy at an out... ...
